Which primary cancers most commonly metastasize to the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Cancers That Most Commonly Metastasize to the Liver

The gastrointestinal tract—particularly colorectal cancer—is the leading source of liver metastases, followed by pancreatic, breast, and lung cancers. 1

Most Common Primary Sources

Colorectal Cancer (Highest Frequency)

  • Colorectal cancer accounts for approximately 80% of all metastatic spread to the liver, making it the single most common primary tumor causing hepatic metastases. 2, 1
  • Among patients diagnosed with colorectal cancer, approximately 50-60% will develop metastases during their disease course, with 80-90% of these involving the liver. 3
  • About 20-34% of colorectal cancer patients present with synchronous liver metastases at initial diagnosis. 3
  • Autopsy studies reveal that more than half of patients dying from colorectal cancer have liver metastases, and in one-third of cases, the liver is the only site of metastatic disease. 3

Other Gastrointestinal Malignancies

  • Pancreatic cancer is identified as a frequent contributor to liver metastases after colorectal tumors. 1
  • Gastric carcinoma represents another common gastrointestinal source of hepatic metastases. 4

Secondary Common Sources

Breast Cancer

  • Breast cancer commonly metastasizes to the liver and frequently exhibits central necrosis in hepatic lesions. 5, 1

Lung Cancer

  • Lung cancer frequently spreads to the liver, with pulmonary adenocarcinoma metastases often developing extensive central necrosis. 5, 1

Less Common But Clinically Important Sources

Neuroendocrine Tumors

  • Well-differentiated ileal carcinoid tumors are the most documented source of pseudocystic hepatic metastases, often appearing multilocular with thick septa and peripheral enhancement. 5
  • Neuroendocrine tumors represent an important subset where surgical resection of liver metastases may offer curative potential in selected patients. 6, 7

Melanoma

  • Melanoma (including ocular melanoma) can generate hepatic metastases that are cystic or display extensive central necrosis due to high vascularity and propensity for hemorrhage. 5, 1

Renal Cell Carcinoma

  • Renal cell carcinoma commonly forms hypervascular hepatic metastases that may develop large zones of central necrosis. 5, 1

Other Sources

  • Ovarian and thyroid carcinomas may produce cystic-appearing liver lesions secondary to intratumoral hemorrhage. 5
  • Sarcoma, including gastrointestinal sarcoma, may metastasize to the liver. 1, 6

Clinical Context and Prognostic Implications

The liver is one of the most common sites for hematogenous metastatic spread across multiple tumor types, with metastatic lesions representing the most common malignant liver tumors overall. 8, 7

Key Prognostic Factors

  • Synchronous metastatic colorectal liver disease is associated with more extensive disease burden and worse prognosis compared to metachronous metastases. 3
  • The presence of extrahepatic metastatic disease, more than 3 tumors, and disease-free interval less than 12 months are associated with poor prognosis. 3

Treatment Considerations

  • Surgical resection remains the only potentially curative treatment for selected patients with resectable liver metastases, particularly from colorectal cancer and neuroendocrine tumors, with 5-year survival rates of 25-46%. 6, 7
  • For patients with liver-only metastatic disease from colorectal cancer, complete surgical resection offers the best chance for long-term survival. 3

References

Guideline

Frequency of Primary Tumors Causing Hepatic Metastases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Kolorektal Kanser Metastazları

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Imaging and Diagnostic Features of Cystic and Necrotic Liver Metastases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Management of hepatic metastases.

Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1999

Research

Cancers Metastatic to the Liver.

The Surgical clinics of North America, 2020

Research

Liver metastases.

Nature reviews. Disease primers, 2021

Related Questions

What is the best next step for a patient with suspected liver metastases who has not been biopsied and now presents with a clearly visualized hepatic lesion on triple‑phase computed tomography?
Do you consult a gastroenterologist (GI) for a patient with liver metastases (mets)?
Can markers from a liver metastatic lesion biopsy help identify the possible primary origin of cancer?
What is the recommended treatment for multiple metastatic lesions in the liver?
What is the best approach to manage a patient with liver metastasis?
What aerobic exercise is most effective for weight loss in generally healthy adults?
What is the recommended dosing regimen, contraindications, monitoring requirements, and duration of therapy for acamprosate in adults with alcohol dependence after detoxification?
What are the possible causes and recommended management for a wide QRS complex in lead V5 on an ECG?
I had a Clostridioides difficile infection last year while taking dexlansoprazole (Dexilant) 60 mg as part of quadruple therapy for Helicobacter pylori; should I be concerned about restarting dexlansoprazole now?
What is the recommended acamprosate dosing regimen for an adult with alcohol dependence, including initiation after at least three days of abstinence, dose adjustments for mild to moderate renal impairment (creatinine clearance 30–60 mL/min), contraindications (age < 18, severe hepatic impairment, creatinine clearance < 30 mL/min), and recommended treatment duration?
What is the appropriate moderate‑intensity heart‑rate range for weight loss in a generally healthy adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.